Global Nuclear Medicine Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global nuclear medicine market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global nuclear medicine market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Radiotherapeutics - Market size and forecast 2022-2027
Exhibit 34: Chart on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
6.4 Equipment (SPECT and PET) - Market size and forecast 2022-2027
Exhibit 38: Chart on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application
7.1 Market segments
Exhibit 44: Chart on Application - Market share 2022-2027 (%)
Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Oncology - Market size and forecast 2022-2027
Exhibit 48: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
7.4 Cardiology - Market size and forecast 2022-2027
Exhibit 52: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
7.5 Neurology - Market size and forecast 2022-2027
Exhibit 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by Application
Exhibit 64: Market opportunity by Application ($ million)
Exhibit 65: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Japan - Market size and forecast 2022-2027
Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Bayer AG
Exhibit 115: Bayer AG - Overview
Exhibit 116: Bayer AG - Business segments
Exhibit 117: Bayer AG - Key news
Exhibit 118: Bayer AG - Key offerings
Exhibit 119: Bayer AG - Segment focus
12.4 Bracco Spa
Exhibit 120: Bracco Spa - Overview
Exhibit 121: Bracco Spa - Product / Service
Exhibit 122: Bracco Spa - Key offerings
12.5 Cardinal Health Inc.
Exhibit 123: Cardinal Health Inc. - Overview
Exhibit 124: Cardinal Health Inc. - Business segments
Exhibit 125: Cardinal Health Inc. - Key news
Exhibit 126: Cardinal Health Inc. - Key offerings
Exhibit 127: Cardinal Health Inc. - Segment focus
12.6 Eckert and Ziegler AG
Exhibit 128: Eckert and Ziegler AG - Overview
Exhibit 129: Eckert and Ziegler AG - Business segments
Exhibit 130: Eckert and Ziegler AG - Key news
Exhibit 131: Eckert and Ziegler AG - Key offerings
Exhibit 132: Eckert and Ziegler AG - Segment focus
12.7 ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
Exhibit 133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
Exhibit 134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
Exhibit 135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
12.8 GE Healthcare Technologies Inc.
Exhibit 136: GE Healthcare Technologies Inc. - Overview
Exhibit 137: GE Healthcare Technologies Inc. - Business segments
Exhibit 138: GE Healthcare Technologies Inc. - Key offerings
Exhibit 139: GE Healthcare Technologies Inc. - Segment focus
12.9 IBA Radiopharma Solutions
Exhibit 140: IBA Radiopharma Solutions - Overview
Exhibit 141: IBA Radiopharma Solutions - Business segments
Exhibit 142: IBA Radiopharma Solutions - Key offerings
Exhibit 143: IBA Radiopharma Solutions - Segment focus
12.10 Jubilant Pharmova Ltd.
Exhibit 144: Jubilant Pharmova Ltd. - Overview
Exhibit 145: Jubilant Pharmova Ltd. - Business segments
Exhibit 146: Jubilant Pharmova Ltd. - Key news
Exhibit 147: Jubilant Pharmova Ltd. - Key offerings
Exhibit 148: Jubilant Pharmova Ltd. - Segment focus
12.11 Koninklijke Philips NV
Exhibit 149: Koninklijke Philips NV - Overview
Exhibit 150: Koninklijke Philips NV - Business segments
Exhibit 151: Koninklijke Philips NV - Key news
Exhibit 152: Koninklijke Philips NV - Key offerings
Exhibit 153: Koninklijke Philips NV - Segment focus
12.12 Mallinckrodt Plc
Exhibit 154: Mallinckrodt Plc - Overview
Exhibit 155: Mallinckrodt Plc - Business segments
Exhibit 156: Mallinckrodt Plc - Key news
Exhibit 157: Mallinckrodt Plc - Key offerings
Exhibit 158: Mallinckrodt Plc - Segment focus
12.13 Medi-Radiopharma
Exhibit 159: Medi-Radiopharma - Overview
Exhibit 160: Medi-Radiopharma - Product / Service
Exhibit 161: Medi-Radiopharma - Key offerings
12.14 Necsa
Exhibit 162: Necsa - Overview
Exhibit 163: Necsa - Product / Service
Exhibit 164: Necsa - Key offerings
12.15 Novartis AG
Exhibit 165: Novartis AG - Overview
Exhibit 166: Novartis AG - Business segments
Exhibit 167: Novartis AG - Key offerings
Exhibit 168: Novartis AG - Segment focus
12.16 Siemens Healthineers AG
Exhibit 169: Siemens Healthineers AG - Overview
Exhibit 170: Siemens Healthineers AG - Business segments
Exhibit 171: Siemens Healthineers AG - Key news
Exhibit 172: Siemens Healthineers AG - Key offerings
Exhibit 173: Siemens Healthineers AG - Segment focus
12.17 Sirtex Medical Pty Ltd.
Exhibit 174: Sirtex Medical Pty Ltd. - Overview
Exhibit 175: Sirtex Medical Pty Ltd. - Product / Service
Exhibit 176: Sirtex Medical Pty Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global nuclear medicine market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Radiotherapeutics - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Radiotherapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Equipment (SPECT and PET) - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Product ($ million)
Exhibits 43: Data Table on Market opportunity by Product ($ million)
Exhibits 44: Chart on Application - Market share 2022-2027 (%)
Exhibits 45: Data Table on Application - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Application
Exhibits 47: Data Table on Comparison by Application
Exhibits 48: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Cardiology - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 64: Market opportunity by Application ($ million)
Exhibits 65: Data Table on Market opportunity by Application ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2022 and 2027
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Bayer AG - Overview
Exhibits 116: Bayer AG - Business segments
Exhibits 117: Bayer AG - Key news
Exhibits 118: Bayer AG - Key offerings
Exhibits 119: Bayer AG - Segment focus
Exhibits 120: Bracco Spa - Overview
Exhibits 121: Bracco Spa - Product / Service
Exhibits 122: Bracco Spa - Key offerings
Exhibits 123: Cardinal Health Inc. - Overview
Exhibits 124: Cardinal Health Inc. - Business segments
Exhibits 125: Cardinal Health Inc. - Key news
Exhibits 126: Cardinal Health Inc. - Key offerings
Exhibits 127: Cardinal Health Inc. - Segment focus
Exhibits 128: Eckert and Ziegler AG - Overview
Exhibits 129: Eckert and Ziegler AG - Business segments
Exhibits 130: Eckert and Ziegler AG - Key news
Exhibits 131: Eckert and Ziegler AG - Key offerings
Exhibits 132: Eckert and Ziegler AG - Segment focus
Exhibits 133: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
Exhibits 134: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
Exhibits 135: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
Exhibits 136: GE Healthcare Technologies Inc. - Overview
Exhibits 137: GE Healthcare Technologies Inc. - Business segments
Exhibits 138: GE Healthcare Technologies Inc. - Key offerings
Exhibits 139: GE Healthcare Technologies Inc. - Segment focus
Exhibits 140: IBA Radiopharma Solutions - Overview
Exhibits 141: IBA Radiopharma Solutions - Business segments
Exhibits 142: IBA Radiopharma Solutions - Key offerings
Exhibits 143: IBA Radiopharma Solutions - Segment focus
Exhibits 144: Jubilant Pharmova Ltd. - Overview
Exhibits 145: Jubilant Pharmova Ltd. - Business segments
Exhibits 146: Jubilant Pharmova Ltd. - Key news
Exhibits 147: Jubilant Pharmova Ltd. - Key offerings
Exhibits 148: Jubilant Pharmova Ltd. - Segment focus
Exhibits 149: Koninklijke Philips NV - Overview
Exhibits 150: Koninklijke Philips NV - Business segments
Exhibits 151: Koninklijke Philips NV - Key news
Exhibits 152: Koninklijke Philips NV - Key offerings
Exhibits 153: Koninklijke Philips NV - Segment focus
Exhibits 154: Mallinckrodt Plc - Overview
Exhibits 155: Mallinckrodt Plc - Business segments
Exhibits 156: Mallinckrodt Plc - Key news
Exhibits 157: Mallinckrodt Plc - Key offerings
Exhibits 158: Mallinckrodt Plc - Segment focus
Exhibits 159: Medi-Radiopharma - Overview
Exhibits 160: Medi-Radiopharma - Product / Service
Exhibits 161: Medi-Radiopharma - Key offerings
Exhibits 162: Necsa - Overview
Exhibits 163: Necsa - Product / Service
Exhibits 164: Necsa - Key offerings
Exhibits 165: Novartis AG - Overview
Exhibits 166: Novartis AG - Business segments
Exhibits 167: Novartis AG - Key offerings
Exhibits 168: Novartis AG - Segment focus
Exhibits 169: Siemens Healthineers AG - Overview
Exhibits 170: Siemens Healthineers AG - Business segments
Exhibits 171: Siemens Healthineers AG - Key news
Exhibits 172: Siemens Healthineers AG - Key offerings
Exhibits 173: Siemens Healthineers AG - Segment focus
Exhibits 174: Sirtex Medical Pty Ltd. - Overview
Exhibits 175: Sirtex Medical Pty Ltd. - Product / Service
Exhibits 176: Sirtex Medical Pty Ltd. - Key offerings
Exhibits 177: Inclusions checklist
Exhibits 178: Exclusions checklist
Exhibits 179: Currency conversion rates for US$
Exhibits 180: Research methodology
Exhibits 181: Validation techniques employed for market sizing
Exhibits 182: Information sources
Exhibits 183: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global nuclear medicine market: Bayer AG, Bracco Spa, Cardinal Health Inc., Eckert and Ziegler AG, ECZACIBASI MONROL NUCLEAR PRODUCTS CO., GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Koninklijke Philips NV, Lantheus Holdings Inc., Mallinckrodt Plc, Medi-Radiopharma, Mirion Technologies Inc., Necsa, Novartis AG, Siemens Healthineers AG, Sirtex Medical Pty Ltd., Telix Pharmaceuticals Ltd., Tema Sinergie SpA, and TTG Imaging Solutions LLC.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is minimal side effects of the radiopharmaceuticals as compared with its potential benefits.`

According to the report, one of the major drivers for this market is the growing adoption of SPECT/CT hybrid imaging systems.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• Bayer AG
• Bracco Spa
• Cardinal Health Inc.
• Eckert and Ziegler AG
• Eczacibasi Monrol Nuclear Products Co.
• GE Healthcare Technologies Inc.
• IBA Radiopharma Solutions
• Jubilant Pharmova Ltd.
• Koninklijke Philips NV
• Lantheus Holdings Inc.
• Mallinckrodt Plc
• Medi-Radiopharma
• Mirion Technologies Inc.
• Necsa
• Novartis AG
• Siemens Healthineers AG
• Sirtex Medical Pty Ltd.
• Telix Pharmaceuticals Ltd.
• Tema Sinergie SpA
• TTG Imaging Solutions LLC